Cellular and molecular crosstalk between leptin receptor and estrogen receptor-α in breast cancer: Molecular basis for a novel therapeutic setting

Endocrine-Related Cancer

Volumn 17, Issue 2, 2010, Pages 373-382

  Fusco, Roberta ^a   Galgani, Mario ^a,b   Procaccini, Claudio ^a,b   Franco, Renato ^c   Pirozzi, Giuseppe ^c   Fucci, Laura ^a   Laccetti, Paolo ^a   Matarese, Giuseppe ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; LEPTIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCLONAL ANTIBODY; RECOMBINANT LEPTIN; SMALL INTERFERING RNA; STAT3 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CELL LINE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LEPTIN; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM STAGING; PHOSPHORYLATION; RECEPTORS, LEPTIN; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; STATISTICS, NONPARAMETRIC;

EID: 77953582276     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0340     Document Type: Article

References (28)

1. Ahima RS & Flier JS 2000 Leptin. Annual Review of Physiology 62 413-437.
2. Allred DC, Harvey JM, Berardo M & Clark GM 1998 Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Modern Pathology 11 155-168. (Pubitemid 28144151)
3. Bernstein L & Ross RK 1993 Endogenous hormones and breast cancer risk. Epidemiologic Reviews 15 48-65. (Pubitemid 23269070)
4. Carroll KK 2003 Obesity as a risk factor for certain types of cancer. Lipids 11 1055-1059.
5. Chehab FF, Lim ME & Lu R 1996 Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nature Genetics 12 318-320.
6. Cohen MM Jr 2006 Role of leptin in regulating appetite, neuroendocrine function, and bone remodeling. American Journal of Medical Genetics 140A 515-524.
7. Fazeli M, Zarkesh-Esfahani H, Wu Z, Maamra M, Bidlingmaier M, Pockley AG, Watson P, Matarese G, Strasburger CJ & Ross RJ 2006 Identification of a monoclonal antibody against the leptin receptor that acts as an antagonist and blocks human monocyte and T cell activation. Journal of Immunological Methods 312 190-200.
8. Fiorio E, Mercanti A & Terrasi M 2008 Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis. BMC Cancer 8 305-316.
9. Fontana L 2009 The scientific basis of caloric restriction leading to longer life. Current Opinion in Gastroenterology 25 144-150.
10. Gao Q, Mezei G, Nie Y, Rao Y, Choi CS, Bechmann I, Leranth C, Toran-Allerand D, Priest CA, Roberts JL et al. 2007 Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Nature Medicine 13 89-94.
11. Garofalo C & Surmacz E 2006 Leptin and cancer. Journal of Cell Physiology 1 12-22.
12. Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J, Russo A, Sulkowski S & Surmacz E 2006 Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clinical Cancer Research 12 1447-1453.
13. Grossmann ME, Ray A, Dogan S, Mizuno NK & Cleary MP 2008 Balance of adiponectin and leptin modulates breast cancer cell growth. Cell Research 18 1154-1156.
14. Henderson BE, Ross R & Bernstein L 1988 Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Research 48 246-253. (Pubitemid 18045752)
15. Hu X, Juneja SC, Maihle NJ & Cleary MP 2002 Leptin a growth factor in normal and malignant breast cells and for normal mammary gland development. Journal of the National Cancer Institute 94 1704-1710. (Pubitemid 35446839)
16. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR & Lechler RI 1998 Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394 897-901.
17. Mauro L, Catalano S, Bossi G, Pellegrino M, Barone I, Morales S, Giordano C, Bartella V, Casaburi I & Andò S 2007 Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression. Cancer Research 67 3412-3421.
18. Moore SC, Leitzmann MF, Albanes D, Weinstein SJ, Snyder K, Virtamo J, Ahn J, Mayne ST, Yu H, Peters U et al. 2008 Adipokine genes and prostate cancer risk. International Journal of Cancer 4 869-876.
19. Perera CN, Chin HG, Duru N & Camarillo IG 2008 Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression. Journal of Endocrinology 2 221-233.
20. Porta C, Larghi P, Rimoldi M, Grazia Totaro M, Allavena P, Mantovani A & Sica A 2009 Cellular and molecular pathways linking inflammation and cancer. Immunobiology 214 761-777.
21. Rodriguez C, Patel AV, Calle EE, Jacobs EJ, Chao A & Thun MJ 2001 Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiology, Biomarkers & Prevention 4 345-353. (Pubitemid 32703219)
22. Saxena NK, Taliaferro-Smith L, Knight BB, Merlin D, Anania FA, O'Regan RM & Sharma D 2008 Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. Cancer Research 68 9712-9722.
23. Stattin P, Söderberg S, Hallmans G, Bylund A, Kaaks R, Stenman UH, Bergh A & Olsson T 2001 Leptin is associated with increased prostate cancer risk: a nested case-referent study. Journal of Clinical Endocrinology and Metabolism 86 1341-1345.
24. Stephenson GD & Rose DP 2003 Breast cancer and obesity: an update. Nutrition and Cancer 1 1-16.
25. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, Strax P & Pasternack BS 1995 A prospective study of endogenous estrogens and breast cancer in postmenopausal women. Journal of the National Cancer Institute 87 190-197.
26. Woods SC & D'Alessio DA 2008 Central control of body weight and appetite. Journal of Clinical Endocrinology and Metabolism 93 S37-S50.
27. Wu MH, Chou YC, Chou WY, Hsu GC, Chu CH, Yu CP, Yu JC & Sun CA 2009 Circulating levels of leptin, adiposity and breast cancer risk. British Journal of Cancer 100 578-582.
28. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L & Friedman JM 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372 425-432.